Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya

Journal of the International Association of Physicians in AIDS Care

Volumn 8, Issue 3, 2009, Pages 165-169

  Chiller, T M ^a   Polyak, C S ^a   Brooks, J T ^a   Williamson, J ^a   Ochieng, B ^b   Shi, Y P ^a   Ouma, P ^b   Greene, C ^a   Hamel, M ^a   Vulule, J ^b   Bopp, C ^a   Slutsker, L ^b   Mintz, E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Escherichia coli; HIV; Kenya; trimethoprim sulfamethoxazole

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; VITAMIN;

ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; FECES; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; KENYA; MALE; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; HIV INFECTIONS; HUMANS; KENYA; MALE; MIDDLE AGED; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VITAMINS; YOUNG ADULT;

EID: 68149094468     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709333112     Document Type: Article

References (15)

1. WHO Expert Consultation on Cotrimoxazole Prophylaxis in HIV Infection. WHO Technical Report Series, report number WHO/HIV/2006.1. Geneva, Switzerland: World Health Organization ; 2005: 1-35.
2. Anglaret X., Chene G., Attia A., et al. Early chemoprophylaxis with trimethoprim-sulfamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet. 1999 ; 353: 1463-1468. (Pubitemid 29204363)
3. Wiktor SZ, Sassan-Morokro M., Grant AD, et al. Efficacy of trimethoprim-sulfamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial.[erratum appears in Lancet. 1999;353:2078]. Lancet. 1999 ; 353: 1469-1475. (Pubitemid 29204364)
4. Badri M., Ehrlich R., Wood R., Maartens G. Initiating cotrimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS. 2001 ; 15: 1143-1148. (Pubitemid 32549865)
5. Chintu C., Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial [see comment]. Lancet. 2004 ; 364: 1865-1871. (Pubitemid 39536090)
6. Mermin J., Lule J., Ekwaru JP, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet. 2004 ; 364: 1428-1434. (Pubitemid 39370718)
7. Anglaret X., Sylla-Koko F., Bonard D., et al. Susceptibilities to co-trimoxazole of pathogens isolated from blood and stool specimens in Abidjan, Ivory Coast, 1994 to 1996. J Clin Microbiol. 1997 ; 35: 1915. (Pubitemid 27255691)
8. Zachariah R., Harries AD, Spielmann MP, et al. Changes in Escherichia coli resistance to co-trimoxazole in tuberculosis patients and in relation to co-trimoxazole prophylaxis in Thyolo, Malawi. Trans R Soc Trop Med Hyg. 2002 ; 96: 202-204. (Pubitemid 34846570)
9. Central Bureau of Statistics-Kenya MoH-K, and ORC Macro-USA. Kenya Demographic and Health Survey, 2003. Calverton, MD: CBS, MOH, and ORC ; 2004.
10. Nccls. Performance Standards for Antimicrobial Disc Susceptibility Tests: Approved Standard. 7 th ed. NCCLS document M2-A7, 2000. Wayne, PA: NCCLS.
11. Morpeth SC, Thielman NM, Ramadhani HO, et al. Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania. J Acquir Immune Defic Syndr. 2008 ; 47: 585-591. (Pubitemid 351442025)
12. Brooks JT, Ochieng JB, Kumar L., et al. Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis. 2006 ; 43: 393-401. (Pubitemid 44157144)
13. Mastro TD, Nomani NK, Ishaq Z., et al. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J. 1993 ; 12: 824-830. (Pubitemid 23311593)
14. Balis E., Vatopoulos AC, Kanelopoulou M., et al. Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli of the normal human gut flora. J Clin Microbiol. 1996 ; 34: 977-979. (Pubitemid 26091521)
15. Dionisio F., Matic I., Radman M., Rodrigues OR, Taddei F. Plasmids spread very fast in heterogeneous bacterial communities. Genetics. 2002 ; 162: 1525-1532. (Pubitemid 36114643)